CORC  > 复旦大学上海医学院
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
Szarek, Michael; White, Harvey D.; Schwartz, Gregory G.; Alings, Marco; Bhatt, Deepak L.; Bittner, Vera A.; Diaz, Rafael; Edelberg, Jay M.; Goodman, Shaun G.; Hanotin, Corinne
刊名JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2019
卷号73期号:4
关键词acute coronary syndrome alirocumab total events
ISSN号0735-1097
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3599223
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Szarek, Michael,White, Harvey D.,Schwartz, Gregory G.,et al. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,2019,73(4).
APA Szarek, Michael.,White, Harvey D..,Schwartz, Gregory G..,Alings, Marco.,Bhatt, Deepak L..,...&Zobouyan, Isabelle.(2019).Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,73(4).
MLA Szarek, Michael,et al."Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 73.4(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace